Photo: Poor Disabled Children in Ecuador Receive Free Wh... (_new sponsorship program in Ecuador. ...)

Photo: Poor Disabled Children in Ecuador Receive Free Wheelchairs!

Date:9/3/2009

_new">sponsorship program in Ecuador. Free Wheelchair Mission, a California-based nonprofit organization, donated 550 wheelchairs valued at nearly $30,000 to families in Quito and Guayaquil in partnership with Children International, which mobilized its volunteers, beneficiaries and the communities to help assemble the wheelchairs in Ecuador.

"We are pleased to partner with Children International to support the people of Ecuador in this capacity," said Don Schoendorfer, president and founder of Free Wheelchair Mission. "Children International has a long history of global humanitarian work, and we appreciate the opportunity to team with them to address suffering and disability in South America."

Children International's President and CEO Jim Cook said, "Free Wheelchair Mission and Children International's joint effort is changing the lives of children and their families living in crushing poverty in Ecuador. Their donation is providing disabled people independence and dignity they feared they might never have."

About Free Wheelchair Mission:

Free Wheelchair Mission is a humanitarian, international, faith-based, non-profit organization based in Irvine, CA. Through creative partnership with over 200 like-minded groups, FWM has provided over 420,000 wheelchairs to impoverished disabled populations living in 70 underserved regions around the world. To learn more, please go to www.freewheelchairmission.org.

About Children International:

SOURCE Children International
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. Photo: Tanger Outlet Center Shoppers Nationwide can Choose Pink to Fight Breast Cancer
2. Photo: Kyphon and the X-STOP(R) IPD(R) Procedure to be Featured on American Health Radio on Monday, September 24, 2007
3. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
4. Video and Photo: U.S. Department of Health & Human Services and Ad Council Join NFL to Combat Childhood Obesity
5. Photo: Introducing a New Line of Baby and Toddler Shirts that Can Help Protect Innocent Babies During Flu Season
6. Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies
7. Photo: New York Goes Orange for Pumpkin Festival and Lupus Awareness Month
8. Photo: Scientists Complete Genome Sequence of Fungus Responsible for Dandruff, Skin Disorders
9. Photo: New Data Show Gleevec(R) Halts Progression to Advanced Stages of Life-Threatening Form of Leukemia in Sixth Year of Treatment
10. Photo: Two Men Raising Awareness of HIV/AIDS by Running Minimum of a Marathon a Day from San Francisco to Los Angeles
11. Photo: KFC Colonel Original and Look-a-Like Share Eye Treatment Success Story

Post Your Comments:

(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com ... report is available in its catalogue: ... Industry in the U.S. and its ... ,, http://www.reportlinker.com/p0167482/In-Vitro-Diagnostic-Substance-Manufacturing-Industry-in-the-US-and-its-International-Trade-[Q4-2009-Edition].html ,, The ... Industry report provides the latest market ...

(Date:12/15/2009)... Reportlinker.com announces that a ... in its catalogue: ,, ... - Market Forecasts to 2015, Competitive ... ,, http://www.reportlinker.com/p0168099/The-Future-of-Respiratory-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... author has released its latest research ...

(Date:12/15/2009)... Aon Consulting, the global human capital consulting ... AON ), today announced Lisa Zeitel has ... with the Health & Benefits Practice and ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20041215/CGW049LOGO ) ,, ... under the direction of Aon Consulting,s Pharmacy ...

(Date:12/15/2009)... Dec. 15 Hospira, Inc. (NYSE: ... in generic injectable pharmaceuticals, and Orchid Chemicals ... a leading Indian pharmaceuticals company and among ... today announced an agreement for Hospira to ... business for approximately $400 million. ,, ...

(Date:12/15/2009)... acid synthesis in brain cancer cells may offer a ... glioblastomas that are driven by amplified signaling of the ... study by researchers at UCLA,s Jonsson Comprehensive Cancer Center. ... the formation of new membranes. The fatty acids also ... and may be important for regulating cell signaling, said ...

[0] Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition][0] Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] Aon Consulting Adds Senior Vice President to National Pharmacy Practice [0] Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business [0] Targeting brain cancer cell metabolism may provide new treatment

... Champion,SAN FRANCISCO, May 13 Brown & Toland Physicians ... award Lisa Marie Harrison of San Ramon the inaugural ... Bay Area woman who has made dramatic improvements to ... time weighed 235 pounds and smoked heavily. After a ...

... to be Implemented Across Slovenia LJUBLJANA, Slovenia, May 13 ... that it will roll out a new electronic health ... IBM ) technology across the country.(Logo: ... healthcare providers to instantly and accurately check a patient,s ...

... report suggests , , WEDNESDAY, May 13 (HealthDay News) -- ... least one bout of major depression in the past ... received treatment, a new government report released Wednesday shows. ... Services Administration (SAMHSA), the report found that health insurance ...

... that looked at obituary photographs published in one metropolitan newspaper ... appearance, particularly for women. , The study found that the ... younger age than when he or she died more than ... than twice as likely as men to have an obituary ...

... Enables Pulmonx to Develop Both Assessment Tools and ... 13 Pulmonx, a medical device company focused ... today that it has acquired all of the ... (EBV) technology platform and associated intellectual property. Pulmonx ...

... Pregnant women and newborns are at greatest risk ... done to ensure that they receive priority treatment should ... Medical Center (UPMC) and University of Pittsburgh study. The ... , raise concerns about the ability of hospitals to ...

Other Medicine News:Health News:IBM Helps Government of Slovenia to Build Smart Health Insurance System 2 Health News:IBM Helps Government of Slovenia to Build Smart Health Insurance System 3 Health News:Most Depressed Teens Don't Get Treatment 2 Health News:Obituary photos suggest growing bias against aging faces 2 Health News:Obituary photos suggest growing bias against aging faces 3 Health News:Pulmonx Acquires Assets of Emphasys Medical and Unveils Combined Product Portfolio at International Conference of the American Thoracic Society (ATS) Annual Meeting 2 Health News:Pulmonx Acquires Assets of Emphasys Medical and Unveils Combined Product Portfolio at International Conference of the American Thoracic Society (ATS) Annual Meeting 3 Health News:Influenza pandemic planning needed to assure adequate care for pregnant women and newborns 2

From Heart Attack Scare to Half-Marathon IBM Helps Government of Slovenia to Build Smart Health Insurance System Most Depressed Teens Don't Get Treatment Obituary photos suggest growing bias against aging faces Pulmonx Acquires Assets of Emphasys Medical and Unveils Combined Product Portfolio at International Conference of the American Thoracic Society (ATS) Annual Meeting Influenza pandemic planning needed to assure adequate care for pregnant women and newborns

(Date:12/15/2009)... ,, Reportlinker.com announces that a ... its catalogue: ,, Hepatitis B Vaccines ... 2015 ,, http://www.reportlinker.com/p0167309/Hepatitis-B-Vaccines---Pipeline-Analysis-and-Market-Forecasts-to-2015.html ,, ... Market Forecasts to 2015 ,, Summary ... new report, "Hepatitis B Vaccines - Pipeline ...

(Date:12/15/2009)... 15 Reportlinker.com announces that a ... its catalogue: ,, Boehringer Ingelheim GmbH: ... ,, Introduction ,, This analysis ... Boehringer Ingelheim in the Rx pharmaceutical sector. ... pipeline analysis and assessment of financial performance, ...

(Date:12/15/2009)... 15 Waters Corporation (NYSE: ... (v.7.1 SR4), an electronic laboratory notebook solution for ... secure electronic repository that stores and manages all ... and is used to boost efficiency in life ... SAFE-BioPharma digital identity and signature standard. The SAFE-BioPharma ...

Breaking Medicine Technology:Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 2 Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 3 Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 4 Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 5 Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 6 Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 7 Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 2 Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 3 Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 4 Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 5 Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 6 Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 7 Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 2 Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 3 Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 4 Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 5 Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 6 China Yongxin Pharmaceuticals Inc to Distribute Medicines on the Essential Drug List 14997 1 China Yongxin Pharmaceuticals Inc to Distribute Medicines on the Essential Drug List 14997 2 China Yongxin Pharmaceuticals Inc to Distribute Medicines on the Essential Drug List 14997 3 FDA Grants Orphan Drug Designation for 3 4 DAP for LEMS 14995 1 FDA Grants Orphan Drug Designation for 3 4 DAP for LEMS 14995 2 FDA Grants Orphan Drug Designation for 3 4 DAP for LEMS 14995 3 FDA Grants Orphan Drug Designation for 3 4 DAP for LEMS 14995 4 Facial Injectables Emerge From the Recession 6587 1 Facial Injectables Emerge From the Recession 6587 2 Facial Injectables Emerge From the Recession 6587 3

[0] Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 [0] Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile [0] Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard

... ASCO Showed Acceptable Tolerability Profile, ... Low Incidence of Grade 3 and 4 Neuropathy, ... eribulin mesylate (E7389) demonstrated activity in a,heavily pretreated population ... to results of a multi-center Phase II clinical,trial. The ...

... N.J., May 15 Sanofi-aventis,(EURONEXT: SAN and ... the,landmark ATHENA study showed Multaq(R) (dronedarone), a ... atrial fibrillation or atrial flutter,decreased the risk ... by a statistically significant 24% (p=0.00000002), meeting ...

Other Medicine Technology:Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2 Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3 Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 2 Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 3 Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 4 Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 5 Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 6 Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 7

Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation

Super High Density, multi-frequency, convex array, small footprint transducer for scanning during craniotomies....

This unique tiny transducer can be very helpful in tight situations like during a carotid endardarectomy procedure....

... Super High Density, multi-frequency, linear ... the first company to introduce ... and, as a result, changed ... and true workhorse has withstood ...

... Hemispheric Sound Technology, multi-frequency, linear ... transducer is very helpful in ... to be a choice transducer ... scanning. Its high frequency upper ...

Medicine Products:

Multi Frequency Neuro Convex Transducer UST-987.7.5 Multi Frequency Micro Surgery Transducer UST-5531 Multi Frequency Flexible Laparoscopic Transducer UST-5536-7.5 Multi frequency Micro Surgery Transducer UST-533

Photo: Poor Disabled Children in Ecuador Receive Free Wh...(_new sponsorship program in Ecuador. ...),Health